Incidence of potentially human papillomavirus-related neoplasms in the United States, 1978 to 2007

Cancer

Volumn 119, Issue 12, 2013, Pages 2291-2299

  Kurdgelashvili, George ^a,b   Dores, Graça M ^a,c   Srour, Samer A ^a,b   Chaturvedi, Anil K ^c   Huycke, Mark M ^a,b   Devesa, Susan S ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

cancer incidence; epidemiology; human papillomavirus associated neoplasms; preinvasive tumors; squamous cell neoplasms

Indexed keywords

ADULT; ANUS TUMOR; ARTICLE; ETHNICITY; FEMALE; HEAD AND NECK CANCER; HUMAN; INCIDENCE; MALE; PENIS CANCER; PENIS CARCINOMA; PRIORITY JOURNAL; RACE; UNITED STATES; UTERINE CERVIX CARCINOMA; VAGINA CARCINOMA; VULVA CARCINOMA; WART VIRUS;

ADOLESCENT; ADULT; AGED; ANUS NEOPLASMS; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PENILE NEOPLASMS; SEER PROGRAM; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VAGINAL NEOPLASMS; VULVAR NEOPLASMS; YOUNG ADULT;

EID: 84878581323     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.27989     Document Type: Article

References (36)

1. US Food and Drug Administration. Vaccines: approved products. http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm094042. htm. Accessed September 26, 2012.
2. Brotherton JM, Fridman M, May CL, Chappell G, Saville AM, Gertig DM,. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet. 2011; 377: 2085-2092.
3. Gillison ML, Chaturvedi AK, Lowy DR,. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer. 2008; 113 (10 suppl): 3036-3046.
4. Copeland G, Datta SD, Spivak G, Garvin AD, Cote ML,. Total burden and incidence of in situ and invasive cervical carcinoma in Michigan, 1985-2003. Cancer. 2008; 113 (10 suppl): 2946-2954.
5. Joseph DA, Miller JW, Wu X, et al. Understanding the burden of human papillomavirus-associated anal cancers in the US. Cancer. 2008; 113 (10 suppl): 2892-2900.
6. Sturgeon SR, Brinton LA, Devesa SS, Kurman RJ,. In situ and invasive vulvar cancer incidence trends (1973 to 1987). Am J Obstet Gynecol. 1992; 166: 1482-1485.
7. Wu X, Matanoski G, Chen VW, et al. Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States. Cancer. 2008; 113 (10 suppl): 2873-2882.
8. Darragh TM, Colgan TJ, Cox JT, et al. The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Dis. 2012; 16: 205-242.
9. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER,; Centers for Disease Control and Prevention; Advisory Committee on Immunization Practices. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007; 56 (RR-2): 1-24.
10. Chaturvedi AK, Engels EA, Anderson WF, Gillison ML,. Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol. 2008; 26: 612-619.
11. Surveillance, Epidemiology and End Results (SEER) Program (www.seer.cancer.gov) SEER Stat Database: Incidence-SEER-9 Regs Research Data, Nov 2010 Sub (1973-2008), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2011, based on the November 2010 submission.
12. Surveillance, Epidemiology and End Results (SEER) Program (www.seer.cancer.gov) SEER Stat Database: Incidence-SEER-13 Regs Research Data, Nov 2010 Sub (1992-2008), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2011, based on the November 2010 submission.
13. Fritz A, Percy C, Jack A, et al, editors. International Classification of Diseases for Oncology. 3rd edition. Geneva, Switzerland: World Health Organization; 2000.
14. Devesa SS, Donaldson J, Fears T,. Graphical presentation of trends in rates. Am J Epidemiol. 1995; 141: 300-304.
15. Barnholtz-Sloan JS, Maldonado JL, Pow-sang J, Giuliano AR,. Incidence trends in primary malignant penile cancer. Urol Oncol. 2007; 25: 361-367.
16. Goodman MT, Hernandez BY, Shvetsov YB,. Demographic and pathologic differences in the incidence of invasive penile cancer in the United States, 1995-2003. Cancer Epidemiol Biomarkers Prev. 2007; 16: 1833-1839.
17. Pukkala E, Weiderpass E,. Socio-economic differences in incidence rates of cancers of the male genital organs in Finland, 1971-95. Int J Cancer. 2002; 102: 643-648.
18. Parkin DM, Bray F,. Chapter 2: The burden of HPV-related cancers. Vaccine. 2006; 24 (suppl 3): S3/11-25.
19. Graafland NM, Verhoeven RH, Coebergh JW, Horenblas S,. Incidence trends and survival of penile squamous cell carcinoma in the Netherlands. Int J Cancer. 2010; 128: 426-432.
20. Simard EP, Pfeiffer RM, Engels EA,. Spectrum of cancer risk late after AIDS onset in the United States. Arch Intern Med. 2010; 170: 1337-1345.
21. Rippentrop JM, Joslyn SA, Konety BR,. Squamous cell carcinoma of the penis: evaluation of data from the surveillance, epidemiology, and end results program. Cancer. 2004; 101: 1357-1363.
22. Chaturvedi AK, Madeleine MM, Biggar RJ, Engels EA,. Risk of human papillomavirus-associated cancers among persons with AIDS. J Natl Cancer Inst. 2009; 101: 1120-1130.
23. Wideroff L, Schottenfeld D,. Penile cancer. In:, Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention. 3rd edition. New York: Oxford University Press; 2006: 1166-1172.
24. Scholefield JH, Harris D, Radcliffe A,. Guidelines for management of anal intraepithelial neoplasia. Colorectal Dis. 2011; 13 (suppl 1): 3-10.
25. Cook MB, Dawsey SM, Freedman ND, et al. Sex disparities in cancer incidence by period and age. Cancer Epidemiol Biomarkers Prev. 2009; 18: 1174-1182.
26. Shiels MS, Pfeiffer RM, Chaturvedi AK, Kreimer AR, Engels EA,. Impact of the HIV epidemic on the incidence rates of anal cancer in the United States. J Natl Cancer Inst. 2012; 104: 1591-1598.
27. Shiels MS, Pfeiffer RM, Gail MH, et al. Cancer burden in the HIV-infected population in the United States. J Natl Cancer Inst. 2011; 103: 753-762.
28. Kreimer AR, González P, Katki HA, et al. CVT Vaccine Group. Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial. Lancet Oncol. 2011; 12: 862-870.
29. Palefsky JM, Giuliano AR, Goldstone S, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med. 2011; 365: 1576-1585.
30. Swedish KA, Factor SH, Goldstone SE,. Prevention of recurrent high-grade anal neoplasia with quadrivalent human papillomavirus vaccination of men who have sex with men: a nonconcurrent cohort study. Clin Infect Dis. 2012; 54: 891-898.
31. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM,. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA. 1999; 281: 1822-1829.
32. Machalek DA, Poynten M, Jin F, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol. 2012; 13: 487-500.
33. Fakhry C, Rosenthal BT, Clark DP, Gillison ML,. Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal "pap-test equivalent" in high-risk populations. Cancer Prev Res (Phila). 2011; 4: 1378-1384.
34. Chaturvedi AK, Engels EA, Pfeiffer RM, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol. 2011; 29: 4294-4301.
35. Brown LM, Check DP, Devesa SS,. Oropharyngeal cancer incidence trends: diminishing racial disparities. Cancer Causes Control. 2011; 22: 753-763.
36. Taylor LD, Hariri S, Sternberg M, Dunne EF, Markowitz LE,. Human papillomavirus vaccine coverage in the United States, National Health and Nutrition Examination Survey, 2007-2008. Prev Med. 2011; 52: 398-400.